Immediate Impact
6 from Science/Nature 53 standout
Citing Papers
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
2024 Standout
Ion Mobility Mass Spectrometry (IM-MS) for Structural Biology: Insights Gained by Measuring Mass, Charge, and Collision Cross Section
2023 Standout
Works of E. Lohrmann being referenced
First-MIND: A phase Ib, open-label, randomized study to assess safety of tafasitamab (tafa) or tafa + lenalidomide (LEN) in addition to R-CHOP in patients with newly diagnosed DLBCL.
2021
Safety ofL -proline as a stabilizer for immunoglobulin products
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| E. Lohrmann | 323 | 159 | 28 | 93 | 24 | 471 | |
| Thomas Schmidt‐Rose | 314 | 146 | 22 | 119 | 13 | 474 | |
| W.-M. Weber | 328 | 103 | 17 | 25 | 21 | 544 | |
| Rosemary Murray | 301 | 99 | 35 | 128 | 18 | 534 | |
| C.L. Johnson | 307 | 155 | 18 | 52 | 20 | 535 | |
| Clive Ellory | 286 | 89 | 18 | 59 | 20 | 421 | |
| Corinna Helmle‐Kolb | 455 | 53 | 22 | 45 | 24 | 561 | |
| Michael Clark | 272 | 48 | 54 | 56 | 17 | 550 | |
| F. Lang | 381 | 133 | 13 | 48 | 11 | 557 | |
| V. Magnelli | 285 | 195 | 40 | 38 | 17 | 448 | |
| Béatrice Rouzaire‐Dubois | 358 | 165 | 18 | 103 | 15 | 468 |
All Works
Loading papers...